In human breast cancer cells, the anti-EMP2 antibody significantly inhibits the EMP2-mediated signal transduction and tumor invasion, and promote cell apoptosis, reducing tumor loading in human xenograft and murine metastatic models [95]. Here, EMP2 is linked to breast carcinoma.